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Abstract Background: Vanadium derivatives have been
reported to display different biological effects, and in
particular antineoplastic activity has been demon-
strated in both in vivo and in vitro studies. Purpose:
To study the effect of two new organic vanadyl(IV)
complexes (one with glucose, GluVO, and the other
with naproxen, NapVO) in osteosarcoma cells. Meth-
ods: UMR106 osteosarcoma cells and, for comparison,
nontransformed MC3T3E1 osteoblasts were used.
Proliferation and differentiation were assessed using
the crystal violet assay and ALP specific activity,
respectively. Morphological alterations were assessed
by light microscopy. Lipid peroxidation was evaluated
in terms of production of thiobarbituric acid-reactive
substances (TBARS) and apoptosis was measured
using annexin V. Extracellular regulated kinase (Erk)
activation was investigated by Western blotting. Re-
sults: Vanadium complexes caused morphological
alterations and they strongly inhibited UMR106 cell
proliferation and differentiation. In contrast, in
MC3T3E1 cells, these vanadium derivatives had a
relatively weak action. In UMR106 tumoral cells there
was a significant increase in TBARS production. Both
vanadium complexes induced apoptosis and activation
of Erk. PD98059, an inhibitor of Erk phosphorylation,
did not block the vanadium-induced antitumoral ac-
tion. However, the antioxidants vitamins C and E
abrogated the apoptosis and TBARS production
induced by the vanadium complexes. Conclusions:
GluVO and NapVO exerted an antitumoral effect in
UM106 osteosarcoma cells. They inhibited cell prolif-
eration and differentiation. While the Erk cascade
seems not to be directly related to the bioactivity of
these vanadium derivatives, the action of both vana-
dium complexes with organic ligands may be mediated
by apoptosis and oxidative stress.
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Introduction
Vanadium derivatives have been reported to display
different biological effects [6, 7, 11, 12, 13, 29]. In
particular, antineoplastic activity has been demon-
strated in both in vivo and in vitro studies [1, 3, 8, 9,
11, 19, 23, 26, 28]. Nevertheless, the mechanism in-
volved in the biological effects of vanadium and its
derivatives remains unclear. Previous experimental
data support the hypothesis that these compounds
exert their actions through oxidative stress [7, 40] or
the regulation of the cellular levels of tyrosine phos-
phorylation through either the inhibition of protein
tyrosine-phosphatases (PTPases) [21, 25, 32, 33] or the
stimulation of tyrosine kinases [34].
We have recently synthesized and characterized two
new vanadyl(IV) derivatives, one with naproxen (Nap-
VO) and the other with glucose (GluVO). Preliminary
results on the biological properties of these compounds
suggest that they could exert antiproliferative effects on
osteoblast-like cells in culture [14, 16, 18].
The aim of the present study was to extend our pre-
vious observations on the bioactivity of NapVO and
GluVO, focusing our attention on their potential anti-
carcinogenic effects in a rat osteosarcoma-derived cell
line (UMR106). Nontumoral MC3T3E1 cells, derived
from mouse calvaria, were included for comparison. The
signal transduction pathways involved in the antitu-
morigenic action of these vanadium derivatives were
also investigated.
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The complexes of vanadium(IV) with naproxen (NapVO) and
glucose (GluVO) were synthesized as previously described [14, 16].
Both ligands were purchased from Sigma Chemical Co. (St. Louis,
Mo.) and vanadyl(IV) sulphate was from Merck (Darmstadt,
Germany).
Cell culture
MC3T3E1 and UMR106 osteoblast-like cells were cultured in
DulbeccoÕs modified EagleÕs medium (DMEM) (Gibco, Gaithers-
burg, Md.) supplemented with 10% (v/v) fetal bovine serum (FBS)
and antibiotics (100 U/ml penicillin and 100 lg/ml streptomycin)
in a humidified atmosphere of 95% air and 5% CO2 as previously
described [6, 13, 33, 35]. For experiments, cells were grown in
proper culture plates. When the cells reached 80% confluence, the
monolayers were washed twice with DMEM and the cells were
incubated with NapVO or GluVO at different doses in serum-free
DMEM for different periods.
Cell proliferation assay
A mitogenic bioassay was carried out as described by Okajima et al.
[31] with some modifications. Briefly, cells in 24-well plates were
washed with phosphate-buffered saline (PBS) and fixed with 5%
glutaraldehyde/PBS for 10 min. The cells were then stained with
0.5%crystal violet/25%methanol for 10 min. The dyewas discarded
and the plate was washed with water and dried. The dye taken up by
the cells was extracted using 0.5 ml/well 0.1 M glycine/HCl buffer,
pH 3.0/30% methanol, and transferred to test tubes. Absorbance
was read at 540 nm. The correlation between cell number and
absorbance at 540 nm has been established previously [6].
Cell differentiation assay
Cells were incubated overnight with NapVO, GluVO or the free
ligands at different doses in serum-free DMEM. The cell layer was
then washed with PBS and solubilized in 0.5 ml 0.1% Triton
X-100. Alkaline phosphatase (ALP) activity was measured spec-
trophotometrically in terms of the initial rates of hydrolysis of
p-nitrophenylphosphate (p-NPP) to p-nitrophenol (p-NP). The
production of p-NP was determined by the absorbance at 405 nm.
Under these experimental conditions, the product formation was
linear for 15 min [6, 27].
Cell morphology
Cells were subcultured in 100-mm dishes and incubated with the
vanadium derivatives overnight. At the end of the incubation
period, the cells were fixed and stained with Giemsa stain [33]. Cell
numbers were determined by counting the stained nuclei in 20 fields
per well. For each treatment, 30–100 cells were analysed per field.
The mitotic index (MI) was defined as the number of mitotic figures
per field over the total number of cells per field [8].
Lipid peroxidation
Lipid peroxidation was measured using a thiobarbituric acid-
reactive species (TBARS) assay according the method of Ohkawa
et al. [30]. Cell extracts were mixed with 20% acetic acid, pH 3.5,
and 0.78% thiobarbituric acid and heated at 95°C for 1 h. The
protein content in the cell extract was assessed by the method of
Bradford [5]. Lipid peroxide levels were expressed in terms of
nanomoles malondialdehyde (MDA) produced per milligram pro-
tein, using 1,1,3,3-tetramethoxypropane as standard [7].
Apoptosis assay
The cells were grown on glass coverslips and apoptosis was mea-
sured using an annexin V-FITC/propidium iodide (PI) assay
(Molecular Probes, Eugene, Ore.) following the recommendations
of the manufacturer. The annexin V/PI method is based on the
observation that in early stages of apoptosis most cell types
translocate phosphatidyl serine from the inner to the outer face of
the plasma membrane. This phospholipid can react with annexin V,
and the cells will show a green fluorescence on the surface. Cells
that have lost membrane integrity (necrotic cells) will have a red
fluorescent nucleus stained with PI.
Early apoptotic stages were characterized by annexin V-FITC-
positive/propidium iodide-negative (V+/PI)) staining while ad-
vanced apoptotic (or apoptotic/necrotic) cells were V+/PI+ [20, 24,
37]. The cell numbers were determined by counting the stained cells
(ranging from 40 to 80 cells per field) in seven fields per coverslip.
The apoptotic index was defined as the ratio of V+/PI) cells per
field to the total cell number per field. Similarly, the necrotic index
was defined as the number of V+/PI+ cells per field over the total
cell number per field.
The effects of vitamins C and E and PD98059 on apoptosis were
also tested as described in the section on Erk detection.
Detection of Erk and PErk by Western blotting
Extracellular regulated kinases (Erk) and their activation
throughout phosphorylation (PErk) were determined as previously
described [17, 18]. The effect of PD98059 (Sigma Chemical Com-
pany, St. Louis, Mo.), an inhibitor of Erk kinases, was also as-
sessed. Cells were preincubated with 50 lM PD98059 in DMEM
without FBS for 1 h. Then either NapVO or GluVO (1000 lM)
was added, and incubation was continued for 1 h at 37°C. Cells
were scraped into LaemmliÕs buffer and the ratio PErk/Erk was
determined by Western blotting. PD98059 was prepared in di-
methyl sulphoxide (DMSO) and a control with DMSO was also
included.
In other series of experiments, the cells were preincubated with
vitamin E (50 lM), vitamin C (50 lM) (Sigma) or a mixture of the
two (50 lM each) for 6 h at 37°C. Then vanadium complexes were
added and the cells were incubated for 1 h at 37°C. The samples
were analysed by Western blotting.
Statistical methods
At least three independent experiments were performed for each
experimental condition. Results are expressed as the means±SEM.
The significance of differences were determined using StudentÕs
t-test.
Results
Bioactivity of NapVO and GluVO in osteoblast-like
cells
We studied the morphological alterations caused by
NapVO and GluVO in osteoblast cell cultures and their
influence on cell proliferation, mitotic index and cell
differentiation.
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Overnight incubation with vanadium derivatives in-
duced morphological changes in both cell lines. Control
MC3T3E1 cells showed the typical features of fibro-
blast-like cultures (Fig. 1a). Cells exhibited processes
connecting them to neighbouring cells. The nuclei were
round and contained chromatin granules, and several
mitotic figures were also observed. NapVO-treated cells
exhibited cytoplasm condensation and vacuolization
with a decrease in cellular processes. Nuclei showed
condensed chromatin granules (Fig. 1b). In MC3T3E1
cells, GluVO caused stronger effects than NapVO,
altering the shape of the nuclei, and inducing fragmen-
tation and condensation of the chromatin (Fig. 1c).
Figure 1d shows the characteristic features of UMR106
cells. They had polygonal morphology, well-stained
nuclei and cytoplasm, and exhibited cellular processes.
Mitotic figures were also present. Nuclear alterations
were observed after incubation with NapVO, which in-
duced a kidney-like shape with dense chromatin gran-
ules (Fig. 1e). GluVO treatment caused a decrease in cell
numbers, and nucleus and cytoplasm condensation, with
loss of cellular processes (Fig. 1f). Besides apoptotic
figures, membrane blebs (arrows) were observed.
Next we studied the effect of these vanadium deriva-
tives on cell proliferation (Fig. 2a, b). Low concentrations
of NapVO exerted a slight but significant mitogenic
effect in MC3T3E1 cells (114% of basal level at 2.5 lM),
whileGluVOonly stimulated cell growth at 25 lM (108%
of basal level; Fig. 2a). At higher concentrations,
both vanadium compounds exerted an antiproliferative
effect, this effect being more potent in the tumoral
UMR106 cells than in the nontransformed MC3T3E1
osteoblasts. GluVO and NapVO caused approximately
17% inhibition of MC3T3E1 cell proliferation at
doses between 50 and 100 lM (Fig. 2a). In UMR106
cells, GluVO was inhibitory at all the tested concentra-
tions (2.5 – 100 lM) and showed a higher potency
than similar doses of NapVO (Fig. 2b). Antiproliferative
effects of NapVO were detected at doses of 50 to
100 lM (ranging from 10% to 35% inhibition). These
vanadium-induced growth inhibition effects were not
reversed by vitamins E and C or PD98059 (data not
shown).
The effects of both vanadium compounds on the
mitotic index in osteoblast cultures were assessed after
staining the monolayer with Giemsa stain (Table 1). The
mitotic index was significantly decreased in MC3T3E1
cells (30% by 100 lM NapVO and 80% by 100 lM
GluVO). In UMR106 cells, 100 lM NapVO decreased
the mitotic index by 25%, while 10 lM GluVO
Fig. 1a–f Effect of vanadium
compounds on cell
morphology. MC3T3E1 (a–c)
or UMR106 (d–f) osteoblasts
were incubated in serum-free
DMEM (basal control; a, d) or
serum-free DMEM plus
100 lM NapVO (b, e) or
100 lM GluVO (c, f) for 24 h.
Cells were fixed and stained
with Giemsa stain. The arrow
(f) indicates plasma membrane
blebs on an apoptotic UMR106




significantly decreased the mitotic index (by 80%). In
addition, 100 lM GluVO, totally blocked the mitogen-
esis of this cell line. This antimitogenic effect was not
observed with the free ligands (data not shown).
The effect of vanadium compounds on the osteo-
blastic phenotype was evaluated by determining the
activity of the specific marker ALP (Fig. 2c, d). In the
nontransformed MC3T3E1 cells, both NapVO and
GluVO (5–25 lM) induced a weak but significant effect
on ALP activity (inhibition ranging from 5% to 20%;
Fig. 2c). In contrast, in UMR106 cells, 2.5–50 lM
NapVO had a more potent effect (about 40% inhibition)
on the ALP specific activity than the same doses of
GluVO (10–35% inhibition; Fig. 2d). However, at
higher doses (75–100 lM), GluVO induced stronger ef-
fects (about 70% inhibition) than NapVO (35–40%
inhibition) in UMR106 cells (Fig. 2d).
Study of the putative mechanisms of action
of GluVO and NapVO
In an attempt to elucidate the possible mechanisms of
action of these vanadium derivatives, we studied their
capacity to induce lipid peroxidation, apoptosis and
activation of Erk.
The role of lipid peroxidation in the bioactivity of
vanadium derivatives was investigated in terms of the
generation of TBARS (Fig. 3). This assay requires high
vanadium concentrations during a relatively short incu-
bation time (4 h), since these end-products have short
half times. GluVO, but not NapVO, caused an increase
in TBARS production in a dose-response manner in tu-
moral UMR106 cells (Fig. 3a). In contrast, neither
vanadyl complex affected the levels of TBARS in the
nontransformed MC3T3E1 cells (Fig. 3a). Furthermore,
Fig. 2a–d Effect of vanadium
compounds on cell proliferation
and differentiation. Osteoblasts
were incubated in serum-free
DMEM alone (basal) or with
different concentrations of
NapVO (open bars) or GluVO
(hatched bars) for 24 h. Cell
proliferation (a, b) was
determined by the crystal violet
bioassay. Osteoblastic
differentiation (c, d) was
assessed in terms of ALP
specific activity. The results are
presented as percentage of basal
levels and are means±SEM
(n=16). *P<0.05, **P<0.01,
#P<0.001, vs basal level
Table 1 Effect of vanadium complexes on the mitotic index of
UMR106 and MC3T3E1 cells. Values are means±SEM (n=60)
Cell line Vanadium
compound
Concentration (lM) Mitotic index
MC3T3E1 – 0.030±3.4 ·10)3
NapVO 10 0.026±4.0 ·10)3
100 0.020±3.6 ·10)3*
GluVO 10 0.020±4.1 ·10)3
100 0.006±2.4 ·10)3**
UMR106 – 0.040±2.6 ·10)3
NapVO 10 0.050±4.5 ·10)3
100 0.030±4.1 ·10)3*
GluVO 10 0.008±2.0 ·10)3**
100 0
*P<0.05, **P<0.001, vs basal level
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the increase in the levels of TBARS induced by 5 mM
GluVO was inhibited 40% by a mixture of reactive
oxygen species (ROS) scavengers (vitamins E and C)
(Fig. 3b).
In a preliminary series of experiments we evaluated
the kinetics of the apoptosis induced by 100 lM of either
NapVO or GluVO in the two cell lines. In the early
apoptotic stages, V+/PI) MC3T3E1 cells were detected
(48% of the cell population), indicating preservation of
the plasma membrane integrity. Membrane blebs were
clearly observed (Fig. 4a). During the advanced apop-
totic stages, V+/PI+ cells were detected (34% of the cell
population). Membrane blebs, spikes and well-stained
nuclei with nucleoli were detected (Fig. 4b). Similar
morphological features were observed in the UMR106
tumoral cells (Fig. 4c, d) (30% of the cell population
apoptotic). Apoptosis was observed in both cell lines as
early as after 4 h and 2 h of incubation with NapVO or
GluVO, respectively. Apoptosis was not detected in cells
incubated with the free ligands (naproxen or glucose).
Dose-response studies showed that NapVO and
GluVO induced apoptosis in both cell lines in a dose-
dependent manner (Fig. 5). NapVO induced the maxi-
mal apoptotic response at doses of 100 lM in both cell
lines (ranging from 2.3- to 4-fold over basal levels;
Fig. 5a, c). No significant alteration in membrane
integrity was observed, suggesting that this vanadium
compound did not induce necrosis in UMR106 cells. In
contrast, in MC3T3E1 cells, 100 lM NapVO caused
necrotic processes (5.6-fold over basal levels; Fig. 5a).
GluVO produced dose-dependent increases in apoptosis
in both cell lines (Fig. 5b, d), the increases ranging from
2.3- to 4.2-fold over basal levels. This compound effec-
tively induced necrosis in UMR106 cells (6-fold over
basal levels; Fig. 5d), but had no effect on necrosis in
MC3T3E1 cells (Fig. 5b).
Preliminary investigation in UMR106 cells showed
that the Erk activation following treatment with the
vanadium complexes began following short incubation
periods, reaching a maximum after 1 h incubation and
remaining at maximal levels for 6 h (data not shown).
Both NapVO and GluVO stimulated Erk phosphoryla-
tion in a dose-response manner in UMR106 cells
(Fig. 6), GluVO more potently than NapVO (400% and
250% over basal levels with 1000 lM GluVO and
NapVO, respectively; Fig. 6b and Fig. 6a, respectively).
Similar results were observed in MC3T3E1 cells (data
not shown).
In order to clarify the signal cascade used by vana-
dium compounds, the effects of PD98059 and a mixture
of antioxidants, vitamins C and E, were investigated. In
the UMR106 cells, Erk phosphorylation induced by
1000 lM GluVO was partially inhibited by PD98059
(Fig. 7). Neither vitamin C nor vitamin E alone was able
to inhibit vanadium-induced Erk phosphorylation (data
not shown), but a mixture of vitamin C and vitamin E
partially blocked the activation induced by 1000 lM
GluVO. Since vanadium compounds can stimulate ROS
production and in turn activate the MAPK cascade, the
combined effects of the antioxidants and PD98059 were
tested. A mixture of PD98059 with vitamins E and C
totally inhibited GluVO-induced Erk activation (Fig. 7).
In order to evaluate the role of oxidative stress and
Erk activation on apoptosis caused by these vanadium
complexes, we preincubated the cells with a mixture of
vitamins C and E (50 lM each) or 10 lM PD98059
(Fig. 8). The mixture of vitamins inhibited NapVO-
induced apoptosis/necrosis in UMR106 cells but not in
MC3T3E1 cells (Fig. 8a, c). In contrast, the GluVO-
induced enhancement of apoptosis/necrosis in the two
cell lines was blocked by the vitamin mixture (Fig. 8b,
d). PD98059 blocked 30% of the apoptosis induced by
NapVO in MC3T3E1 cells but had no effect on apop-
tosis in UMR106 cells. Furthermore, the necrosis
induced by NapVO was totally inhibited by PD98059 in
both cell lines (Fig. 8a, c). In contrast, PD98059 blocked
60% of the apoptosis and 100% of the necrosis induced
by GluVO in MC3T3E1 cells, but had no effect on the
GluVO-induced effects in UMR106 cells. Thus, Erk
Fig. 3a, b Effect of vanadium derivatives on lipid peroxidation.
Osteoblasts were incubated in serum-free DMEM alone (basal) or
with vanadium compounds for 4 h. Lipid peroxidation was
assessed in terms of TBARS production. a Dose-response curve
for UMR106 (filled symbols) or MC3T3E1 (open symbols) (circles
GluVO, triangles NapVO). b Effect of ROS scavengers (vitamin E
and C, 50 lM each) on TBARS production induced by 5 mM
GluVO. The results are presented as percentage of basal levels and





with 100 lM NapVO for 4 h.





cells (a) and UMR106 cells (c)
show plasma membrane stained
with annexin V (arrows plasma
blebs). The figures are
representative of the apoptotic
population observed per field
(48% and 30% apoptosis with
100 lM NapVO in MC3T3E1
and UMR106 cells,
respectively). Necrotic
MC3T3E1 cells (b) (34% of the
cell population) and UMR106
cells (d) (14% of the cell
population) stained with
annexin V and PI (arrow
annexin V-labelled plasma
membrane blebs, arrowhead
nucleus stained with PI)
Fig. 5a–d Vanadium-induced
apoptosis in osteoblastic cells.
Osteoblasts were incubated
with different doses of NapVO
(a, c) for 4 h or GluVO (b, d)
for 2 h. Cells were stained with
annexin V (1 lg/ml) and PI
(2.5 lg/ml) for 30 min, fixed
with 4% paraformaldehyde for
15 min and mounted in
fluorescence mounting medium.
The results are presented as
apoptotic cell numbers/total cell
numbers (open bars) or necrotic
cell numbers/total cell numbers
(hatched bars) and are
means±SEM (n=4). *P<0.05,
**P<0.01, #P<0.001, vs basal
level
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activation seems to be involved in the effect of both
vanadium compounds in the nontumorigenic MC3T3E1
cells but not in the osteosarcoma UMR106 cells.
Discussion
In recent years there has been increasing interest in the
antineoplastic properties of vanadium derivatives [1, 9,
28]. Their efficacy in reducing tumour growth both in
vivo and in vitro has been reported [3, 11, 19, 23, 26].
Nevertheless, the mechanism of their action remains
unclear.
As part of a research project devoted to developing
new vanadium derivatives with potential pharmacolog-
ical applications, we have synthesized and characterized
two novel organic complexes of the vanadyl(IV) cation,
one with naproxen and the other with glucose [14, 16]. In
the present work we focused on the putative mechanism
of action of these compounds. First, we evaluated the
effect of GluVO and NapVO on cell morphology, pro-
liferation and differentiation. We observed a biphasic
effect on MC3T3E1 cell proliferation: both vanadium
compounds were stimulatory at low doses (2.5–25 lM)
and inhibitory at higher doses (50–100 lM). These
findings are in agreement with results previously
reported by our group for other vanadium derivatives
[13, 15, 16]. On the contrary, an antimitogenic effect was
observed in UMR106 cells at all the tested concentra-
tions, with GluVO displaying a stronger inhibitory effect
than NapVO. These results are opposite to others pre-
viously obtained on the effects of several vanadium
compounds on the proliferation of tumoral UMR106
cells, since vanadium derivatives cause in general a
stimulatory effect at low doses and have no effect at high
concentrations [2, 6, 13, 16]. It is interesting that neither
the free vanadyl(IV) cation nor the free ligands induced
any antimitogenic effect in tumoral UMR106 cells in the
concentration range tested (2.5–100 lM). These obser-
vations suggest that the complexation of vanadium(IV)
with naproxen or glucose gives it specific and interesting
antitumoral properties. These results are in agreement
with the changes in the mitotic index obtained in the two
cell lines for both vanadium compounds.
Studies on cell differentiation, evaluated in terms of
ALP specific activity, showed that both vanadium
derivatives had a negative effect on the expression of this
phenotypic marker in UMR106 cells, an effect similar to
that of other vanadium complexes [2, 6, 13, 15]. The
inhibitory effect was almost constant for NapVO (40%
inhibition) over the whole range of concentrations, but
was dose-dependent for GluVO. In contrast, in
MC3T3E1 cells there was a slight inhibitory effect at low
doses but no effect at high doses (50–100 lM).
The Erk pathway is classically recognized as a key
transducer in the signal cascade mediating cell prolifer-
Fig. 6a, b Erk activation by vanadium complexes in UMR106
cells. The effects of different doses of NapVO (a) and GluVO (b)
were evaluated. After incubation with the vanadium compounds
(1 h at 37°C), cells were scraped into LaemmliÕs buffer and analysed
by Western blotting using specific antibodies against Erk and PErk.
The results are presented as the percentage relative intensity of
PErk/Erk and are means±SEM (n=3). The basal condition
(without vanadium) represents 100% Erk activation. **P<0.01,
#P<0.001, vs basal level
Fig. 7 Effect of Erk activation inhibitors. Cells were preincubated
with 50 lM PD98059 (1 h) or a mixture of vitamins E and C
(50 lM each, 6 h). After incubation with 1000 lM GluVO for 1 h,
Erk was analysed by Western blotting. The results are presented as
percentage of relative intensity of PErk/Erk and are means±SEM
(n=3). The basal condition (without vanadium) represents 100%
Erk activation. #P<0.001, vs basal level
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ation and differentiation [38]. The Erk pathway has also
been associated with protection from apoptosis [39].
However, recent investigations have shown that the Erk
pathway also mediates cell cycle arrest, antiproliferation,
and apoptotic and nonapoptotic death [4]. In an attempt
to elucidate the mechanism involved in the effects of
NapVO and GluVO, we studied the relationship be-
tween Erk pathway activation induced by these vana-
dium compounds and their effects on cell proliferation
and differentiation. As Erk activation is a fast and
transient process, we assessed, as others have done [10],
the effects of vanadium compounds at 100–1000 lM
during 1 h of incubation. A dose-dependent increase in
Erk phosphorylation was observed in both cell lines, and
this effect was blocked by PD98059 or a mixture of
vitamins C and E. An oxidative mechanism seems to be
involved in Erk phosphorylation, as others have previ-
ously proposed for vanadate [25, 38, 42]. Nevertheless,
Erk activation seems not to be related to the effects of
either NapVO or GluVO on cell proliferation or on
osteoblastic differentiation, since pretreatment with
PD098059 did not reverse these effects.
Apoptosis is a physiological process of cell death to
provide protection against injuring agents. In some
diseases such as cancer, there is an imbalance between
the rate of cell proliferation and cell death [22, 40]. In
recent years, different metal ions have been reported to
be able to induce apoptosis in diverse cell culture
models [20, 22]. The morphological techniques used
are gold standards for the identification of apoptosis
[41]. Apoptotic morphological features observed by
microscopy could be used to define this phenomenon,
at least qualitatively. The present study showed the
ability of NapVO and GluVO to induce apoptosis and
necrosis in osteoblastic cell lines. Characteristic apop-
totic features, such as membrane blebs and cytoplasm
condensation, were observed after treatment with the
vanadium derivatives. Quantification of the apoptosis
showed that the effect was stronger in tumoral
UMR106 cells than in nontransformed MC3T3E1
cells. NapVO also induced necrosis in both cell lines,
while GluVO stimulated necrotic processes only in the
UMR106 cells. As has been found for other vanadium
derivatives, these compounds also stimulate the gen-
eration of ROS [7]. Hydroxyl radicals as well as other
ROS seem to be apoptosis inducers, probably acting
by interacting with the plasma membrane, leading to
lipid peroxidation or the activation of cellular apop-
totic pathways [36, 40]. To study the effect of ROS
production in our model, we analysed the effect of
ROS scavengers upon the apoptosis induced by Nap-
VO and GluVO in both cell lines. Our results showed
that vitamins C and E partially blocked the apoptotic
action of these compounds.
Taken together, our results indicate that apoptosis
induced by vanadium complexes may be at least medi-
ated by lipid peroxidation. The antitumoral effect of
vanadium compounds in UMR106 osteosarcoma cells
seems to be related to oxidative stress but not to Erk
activation.
Fig. 8a–d Effect of vitamins
and PD98059 on vanadium-
induced apoptosis in
osteoblasts. After overnight
incubation with a mixture of
vitamins E and C (50 lM each),
MC3T3E1 cells (a, b) and
UMR106 cells (c, d) were
incubated with 250 lM NapVO
(4 h) or 250 lM GluVO (2 h).
Apoptosis was assayed as
described in Materials and
methods. The results are
presented as apoptotic cell
numbers/total cell numbers
(open bars) or necrotic cell
numbers/total cell numbers
(hatched bars) and are
means±SEM (n=4). *P<0.05,
**P<0.01, #P<0.001, vs basal
level
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